分类归档 opinion

Special feature of 1905 film network In 2023, the Dragon Boat Festival entered the countdown and won at the starting line. At present, the total box office of the two films is more than 20 million, making them the top seed players.

With the opening of the Dragon Boat Festival, the balance in June is insufficient. In July, which played a connecting role in the summer file, with the addition of two foreign films, the lineup of films was more abundant.

Up to now, in 2023, many imported films have been booked and released in China. Coupled with a number of domestic blockbusters previously scheduled, the box office of the summer file in 2023 will return to the era of 10 billion.

Filmmakers hope that all the films in the schedule will sell well.

It has become normal for the imported movie "Bao Tuan" to land in the first month of the summer file.

The same is true in 2023, with 9 foreign films scheduled for June. Among them, "Transformers 7", "Speed and Passion 10" and many other foreign films are temporarily in the TOP10 of the single-chip box office list in June.

"First of all, many films are scheduled in North America in the summer, and the simultaneous release in the mainland can guarantee the box office revenue of the films. If they are shown later, the pirated resources will be leaked in advance and the plot will be spoiled." Cheng Fei, CEO of Top Data, shared his views on the phenomenon that many imported films choose to be released in summer. He admits that the summer file has a time span of three months, and for imported films, there is plenty of room for box office.

According to the statistics of Top Data’s summer box office in recent years, the primary factor for imported movies to achieve high box office during this period is the quality of film content. For example, in early May, under the premise of serious loss of foreign film audience, with excellent reputation, it achieved almost the same box office results as the previous film. At present, the film has exceeded 36.6 million yuan, ranking 9 th in the single box office list of the mainland film market in June.

Secondly, IP size is also an important factor affecting the box office performance of foreign films in summer. For example, Speed and Passion 10, which is being released, has won a cumulative box office of nearly 1 billion yuan with IP blessing, although its reputation is average.

At present, 20 films have been scheduled in July 2023. In terms of imported movies, Mission Impossible 7 has a high degree of market recognition. In terms of domestic films, etc., the online ticketing platform wants to see the top number of people.

Among these films, Cheng Fei said that "the box office of domestic films is greatly influenced by word of mouth, and the word-of-mouth feedback of the premiere of" octagonal cage "is positive; The "Enthusiasm" unveiled at the Shanghai Film Festival has received rave reviews in the industry; There is no word-of-mouth exposure in the production level, showing a large temperament; It attracted a large audience on the streaming media platform. " In terms of imported films, "Mission Impossible 7" was praised by overseas media in the early stage, or became the box office champion of imported films in summer.

For the cinema, the summer file is also an important schedule that affects the annual revenue.

"I think as a filmmaker, I may prefer to sell all the films in the schedule. After the epidemic, the whole industry is working hard from top to bottom. We don’t want only one explosive movie in a schedule, because one explosive can’t support the whole schedule. " Cai Xiaoxue, director of operation of UME Studios, bluntly said that the efforts of all parties in the film industry are aimed at creating a win-win situation of "letting a hundred flowers blossom and a hundred schools of thought contend". Only when the schedule is good can the market remain dynamic.

At present, the 2023 summer movie list can be described as colorful. Cai Xiaoxue believes that this film list can attract more main moviegoers to enter the cinema. According to the characteristics of the scheduled passenger flow, UME Studios also launched preferential movie viewing activities for students and graduates.

Summer box office may return to the era of 10 billion

In 2019, it became a watershed in the summer box office of the mainland film market.

Since 2015, the overall box office of this period has exceeded the 10 billion mark for five consecutive years and reached a record high of 17.778 billion yuan in 2019. Since then, affected by the epidemic, the box office of the summer file fell to 7.181 billion yuan in 2021 and rose to 9.135 billion yuan in 2022.

By 6: 00 pm on June 20th, the box office of summer file in 2023 had reached 1.66 billion yuan, exceeding the level of the same period last year. In July, due to the rich types of films in the market and the balanced volume, the box office in a single month is expected to create a new high after the epidemic. August, etc., with a certain market recognition.

In this context, the summer file in 2023 is expected to return to the era of billions.

"The first mainland box office of the Megalodon series produced by our Chinese film industry sold for 1 billion yuan. The second new combination with Jason Statham will make the potential audience base even larger. " Cai Xiaoxue admits that he is full of confidence in the return of the summer file in 2023 to the era of 10 billion box office. In the August film list, she believes that Megalodon 2: Abyss can have a good box office performance.

Cheng Fei also believes that it is easier for the summer box office to exceed 10 billion in 2023, but it is difficult to challenge the best results in 2019. At the same time, he also admitted that the market could not reach the best level in history overnight and needed a gradual process. According to Top Box Office Forecast System, the summer box office in 2023 is expected to fluctuate from 11 billion yuan to 13 billion yuan.

As we all know, July and August have become the main ticket warehouses for summer files. According to statistics, in the last five summer vacations, July and August won the monthly box office champion for two times and three times respectively. With the coming of these two months, the competition in the summer movie market will become more intense.

In the summer of 2023, audiences hope to see more excellent films, and filmmakers hope to see more win-win situations. The upcoming Dragon Boat Festival will also set off a wave of movie climax.

CCTV News:In 2023, the scale of China’s import and export increased steadily, and the development quality improved, which enhanced the overall confidence. At the same time, as the economic situation continues to improve and policies continue to strengthen, new growth points such as "new three kinds", emerging markets and new formats will be further cultivated and expanded, which will accumulate more kinetic energy for the steady improvement of foreign trade.

Since the beginning of 2024, this technology company in Jiaxing, Zhejiang Province has been running at full capacity, where about 60 boxes of solar panels are put into containers every day and sent to Germany, Brazil, Spain and other countries.

Lu Zhenyu, Chief Operating Officer of Zhengtai Xinneng Technology:At present, the whole first quarter (production capacity) is full, so we work overtime to catch orders, and there is no holiday during the Spring Festival.

According to customs data, in 2023, the export value of "new three products" such as new energy vehicles, lithium batteries and photovoltaics exported from the Yangtze River Delta region reached 541.92 billion yuan, an increase of 19.7%, achieving double-digit high-speed growth. The total export volume of the Yangtze River Delta’s "New Three Samples" accounts for 51.2% of the whole country.

In 2023, the export growth rate of automobiles, mobile phones and ships in the Yangtze River Delta regions such as Shanghai, Jiangsu, Zhejiang and Anhui reached 56.8%, 41.6% and 40.1% respectively.

Wang Yang, Director of Statistics and Analysis Department of Hangzhou Customs:Hangzhou Customs fully serves the implementation of national strategies such as the integration of the Yangtze River Delta, promotes the innovation of supervision modes such as "group processing trade" and "inspection before shipment", accelerates the cultivation of new kinetic energy of foreign trade, and fully promotes the high-quality development and high-level opening of foreign trade.

2023 is the fifth anniversary of the integration of the Yangtze River Delta as a national strategy. In the past five years, the import and export of the Yangtze River Delta region has increased by 37.3%, accounting for 36.3% of the total import and export value of the country. The Yangtze River Delta region is leading the national import and export to achieve higher quality opening.　

The Yangtze River Delta region accounted for 36.3% of China’s import and export.

The data shows that new quality productivity such as emerging markets, emerging industries and new trade formats has become the main kinetic energy leading the high-quality development of imports and exports in the Yangtze River Delta region.

In 2023, the import and export of the Yangtze River Delta region reached 15.17 trillion yuan, accounting for 36.3% of the country’s total import and export value.

As a core city in the Yangtze River Delta region, Shanghai’s import and export in 2023 was 4.21 trillion yuan, a record high. Automobile exports accounted for more than one-third of the national total, with a cumulative export of 1.895 million vehicles, a year-on-year increase of 36.7%.

Another important growth pole in the Yangtze River Delta region is private enterprises. In 2023, Zhejiang’s import and export performance of private enterprises exceeded 100,000 for the first time, accounting for about one-sixth of the country’s total, driving Zhejiang’s import and export, export and import to rank first in the national growth.

In 2023, the "new three kinds" became the new kinetic energy to pull the "troika". Jiangsu’s "new three kinds" exports lead the country, among which, the export scale of electric manned vehicles increased by 3.6 times year-on-year, mainly sold to the European Union, ASEAN, Australia and other countries and regions.

In addition, the Yangtze River Delta region has the only economic and trade cooperation demonstration zone in China for Central and Eastern European countries, China, Ningbo in 2023 — The demonstration zone of economic and trade cooperation between Central and Eastern European countries and Central and Eastern European countries achieved an import and export trade volume of 50.47 billion yuan, a record high.

The trade layout is diversified and the regional development highlights are numerous.

As national key strategic regions, Beijing-Tianjin-Hebei, Yangtze River Delta and Guangdong-Hong Kong-Macao Greater Bay Area have made outstanding contributions to China’s foreign trade import and export in 2023 by 12%, 36.3% and 19% respectively.

In 2023, the import and export of 9 cities in Guangdong-Hong Kong-Macao Greater Bay Area Mainland was 7.95 trillion yuan, accounting for 19% of the total import and export value of China. The import and export of high-tech products is the highlight of this region, which shows the outstanding advantages in scientific research and development and industrial innovation.

Looking along the eastern coastal areas to the central region, in 2023, the total import and export value of Henan Province was 810.79 billion yuan, ranking first in the central region for 12 consecutive years.

In the northwest of China, Xinjiang has the largest land port facing Central Asia. In 2023, Xinjiang’s foreign trade import and export reached a record high, with a year-on-year increase of 45.9%, and its export scale to five Central Asian countries ranked first in the country.

In the southwest of China, facing ASEAN, China’s largest trading partner for four consecutive years, Yunnan has accelerated the construction of China’s radiation center for South Asia and Southeast Asia, and the trade scale has remained above 100 billion yuan for five consecutive years.

FAW Pentium Pony opened for pre-sale today, with a pre-sale price of 289-34900 yuan, and the new car will be officially listed at the end of May.

The car will be equipped with 9.4 kWh, 9.98 kWh and 13.9 kWh battery packs. The summary pricing of IT House is as follows:

The design of Pentium pony is very cute. The front face is equipped with a rounded lamp group, and the high-profile models will also provide LED light sources. The body structure is a 3-door 4-seat hatchback with rounded lines. The car provides six body colors, including lime, cherry, grape, blueberry, litchi and pearl litchi, to meet the individual needs of different consumers. The body enclosure and rim cover with contrast design also add youthful and energetic elements. At present, the official has not released the body size data of Pentium pony, but it is expected that its overall size will be similar to that of Wuling Hongguang MINIEV of the same level.

The interior design of Pentium Pony is simple and practical. The center console adopts many straight lines, which helps to increase the visual width inside the car. It also adopts a flat-bottomed steering wheel, an integrated cruise/headlight combination switch, and knob shift. In terms of configuration, the official said that the Pentium pony comes standard with the main driver airbag and the front and rear seat belts to ensure the safety of riding. However, in the multimedia entertainment system, at present, there are only radio and USB music functions, but there are no functions such as navigation and reversing images. Whether these functions will be provided on other models will continue to be concerned by IT House.

In terms of power, the Pentium pony is equipped with a single motor with a maximum power of 20 kW. In terms of battery, the car will be equipped with three kinds of battery packs of 9.4 kWh, 9.98 kWh and 13.9 kWh. The pure battery life of CLTC is divided into 122 km and 170 km. The charging port is located under the central cover of the front face, and the left side of the charging port is also provided with a glass water filling port.

This article is reproduced from IT House. The purpose of reprinting is to convey more information, which does not mean that this site agrees with its views and is responsible for its authenticity. If the content, copyright and other issues of the work are involved, please contact IT House to inform us to delete it, and we will delete the content as soon as we receive the notice! This article is for reference only and does not constitute any investment and application suggestions. This site has the final right to interpret this statement.

"internet plus" is entering the medical industry strongly, and traditional pharmaceutical companies have also "touched the net" to explore the blue ocean of Internet medical care. On March 30th, the State Council officially issued the Outline of the National Medical and Health Service System Planning (2015-2020), clearly proposing the active application of new technologies such as mobile Internet, Internet of Things, cloud computing and wearable devices, promoting health information services and smart medical services that benefit all people, and promoting the application of health big data.

Under the favorable situation of many policies such as doctors practicing more and selling drugs on the Internet, pharmaceutical companies are competing to develop Internet medical care. Is this "cake" really so good? Can it fundamentally solve the problem of people’s difficulty in seeing a doctor?

Order of the National Bureau of Medical Treatment and Disability Protection

No.3

The Interim Measures for the Designated Management of Medical Security in Retail Drugstores, which was considered and adopted at the 2nd executive meeting on December 24th, 2020, is hereby promulgated and shall come into force as of February 1st, 2021.

Director Hu Jinglin

December 30, 2020

Interim Measures for the designated management of medical security in retail pharmacies

Chapter I General Principles

the first　In order to strengthen and standardize the designated management of medical security in retail pharmacies, improve the efficiency of the use of medical security funds, and better protect the rights and interests of the majority of insured persons, these measures are formulated in accordance with laws and regulations such as the Social Insurance Law of People’s Republic of China (PRC), the Basic Medical Care and Health Promotion Law of People’s Republic of China (PRC), and the Drug Administration Law of People’s Republic of China (PRC).

the second　The fixed-point management of medical security in retail pharmacies should adhere to the people’s health as the center, follow the principles of basic security, fairness and justice, clear rights and responsibilities, and dynamic balance, strengthen the refined management of medical security, give play to the vitality of the retail pharmacy market, and provide appropriate pharmaceutical services for the insured.

Article　The administrative department of medical security is responsible for formulating the fixed-point management policies of retail pharmacies, and supervising the medical security agencies (hereinafter referred to as "agencies") and designated retail pharmacies in the fixed-point application, professional evaluation, negotiation, agreement conclusion, agreement performance and agreement dissolution. The agency is responsible for determining the designated retail pharmacies, and signing a medical security service agreement with the designated retail pharmacies (hereinafter referred to as the "medical insurance agreement"), providing handling services, and carrying out the management and assessment of the medical insurance agreement. Designated retail pharmacies shall abide by the laws, regulations, rules and relevant policies of medical security and provide pharmaceutical services to the insured in accordance with the provisions.

Chapter II Determination of Designated Retail Drugstores

Article 4　The administrative department of medical security in the overall planning area shall determine the resource allocation of designated retail pharmacies in the overall planning area according to the public health needs, management service needs, income and expenditure of medical security funds, and drug demand of insured persons.

Article 5　Retail pharmacies that have obtained drug business licenses and meet the following conditions may apply for designated medical security:

(1) It has been officially operating at the registered address for at least 3 months;

(2) There is at least one pharmacist who has obtained the qualification certificate of licensed pharmacist or has the professional and technical qualification certificate of pharmacy, clinical pharmacy and traditional Chinese medicine, and the registered place is in the location of the retail pharmacy, and the pharmacist must sign a labor contract for more than one year and within the contract period;

(three) at least two full-time (part-time) medical insurance managers who are familiar with medical insurance laws and regulations and related systems are responsible for the management of medical insurance expenses, and have signed labor contracts for more than one year and within the contract period;

(four) according to the requirements of the quality management standard of drug business, carry out the management of drug classification and zoning, and set up a clear medical insurance drug label for the drugs sold;

(5) Having a medical insurance drug management system, a financial management system, a medical insurance personnel management system, a statistical information management system and a medical insurance expense settlement system that meet the requirements of medical insurance agreement management;

(6) Having information system technology and interface standards that meet the requirements of medical insurance agreement management, realizing effective docking with medical insurance information system, providing direct online settlement for insured persons, establishing basic databases such as medical insurance drugs, and using national unified medical insurance codes according to regulations;

(seven) meet other conditions stipulated by laws and regulations and provincial and above medical security administrative departments.

Article 6　Retail pharmacies to co-ordinate regional agencies to apply for medical security designated, at least provide the following materials:

(1) An application form for designated retail pharmacies;

(2) A copy of the drug business license, business license and ID card of the legal representative, principal responsible person or actual controller;

(3) Licensed pharmacist qualification certificate or relevant certificate of pharmaceutical technicians and a copy of their labor contracts;

(four) a copy of the labor contract of the full-time (part-time) medical insurance management personnel;

(five) the internal management system and financial system corresponding to the medical security policy;

(6) Information system related materials related to medical insurance;

(seven) a predictive analysis report on the use of medical insurance funds after being included in the fixed point;

(eight) other materials provided by the provincial medical security administrative department in accordance with the relevant provisions.

Article 7　Retail pharmacies put forward fixed-point applications, and regional agencies should immediately accept them. If the application materials are incomplete, the agency shall inform the retail pharmacy to supplement them within 5 working days from the date of receiving the materials.

Article 8　As a whole, the regional agency shall organize an evaluation team or entrust a third-party agency that meets the requirements to carry out the evaluation in written form and on-site. The members of the evaluation team are composed of professionals such as medical security, medicine and health, financial management and information technology. From the date of accepting the application materials, the evaluation time shall not exceed 3 months, and the time for replenishing materials in retail pharmacies shall not be included in the evaluation period. The evaluation contents include:

(1) Checking the drug business license, business license and the ID card of the legal representative, the person in charge of the enterprise or the actual controller;

(2) Checking the qualification certificates of licensed pharmacists or pharmaceutical technicians and labor contracts;

(three) check the labor contract of medical insurance full-time (part-time) management personnel;

(four) check the internal management system and financial system corresponding to the medical security policy;

(five) check whether the information system related to medical insurance has the conditions to carry out direct online settlement;

(six) check the identification of medical insurance drugs.

The evaluation results include qualified and unqualified. Overall regional agencies should report the evaluation results to the administrative department of medical security at the same level for the record. For those who pass the assessment, they will be included in the list of retail pharmacies that intend to sign medical insurance agreements and publicized to the public. Those who fail to pass the evaluation shall be informed of their reasons and put forward rectification suggestions. From the date of delivery of the results, the assessment can be organized again after 3 months of rectification. If the assessment is still unqualified, it may not be applied again within 1 year.

The provincial medical security administrative department may, on the basis of these measures, formulate specific evaluation rules according to the actual situation.

Article 9　Coordinating regional agencies and qualified retail pharmacies to negotiate and reach an agreement, the two sides voluntarily sign a medical insurance agreement. In principle, the overall regional agencies at the prefecture level and above shall sign a medical insurance agreement with retail pharmacies and file it with the medical security administrative department at the same level. The medical insurance agreement should clarify the rights, obligations and responsibilities of both parties. Both parties who sign the medical insurance agreement shall strictly implement the medical insurance agreement. The term of medical insurance agreement is generally one year.

Article 10　Co-ordinate regional agencies to announce to the public the information of designated retail pharmacies that have signed medical insurance agreements, including names and addresses, for the insured to choose.

Article 11　Retail pharmacies in any of the following circumstances, shall not accept the designated application:

(1) Failing to perform the responsibility of administrative punishment according to law;

(two) to resort to deceit and other improper means to apply for fixed-point, less than 3 years from the date of discovery;

(3) The medical insurance agreement has been cancelled for less than 3 years due to violation of laws and regulations, or it has been completed for 3 years, but the legal liability for administrative punishment has not been fully fulfilled;

(four) due to serious violation of the medical insurance agreement, the medical insurance agreement has been terminated for less than one year or has been completed for one year, but the liability for breach of contract has not been fully fulfilled;

(five) the legal representative, the person in charge of the enterprise or the actual controller has been terminated by the original designated retail pharmacy due to serious violations of laws and regulations, less than five years;

(six) the legal representative, the person in charge of the enterprise or the actual controller is included in the list of untrustworthy persons;

(seven) other circumstances that are not accepted as prescribed by laws and regulations.

Chapter III Operation Management of Designated Retail Drugstores

Article 12　Designated retail pharmacies have the right to obtain medical insurance settlement fees after providing drug services for insured persons, supervise the performance of agencies, and put forward opinions and suggestions on improving medical security policies.

Article 13　Designated retail pharmacies shall provide services such as drug consultation, drug safety, medical insurance drug sales and medical insurance expense settlement for the insured. Designated retail pharmacies that meet the prescribed conditions may apply to be included in the designated institutions for purchasing drugs for chronic diseases and special diseases in outpatient clinics, and the relevant provisions shall be formulated separately by the regional medical security department as a whole.

The fees not paid by the agency, the quality deposit deducted by the designated retail pharmacies according to the medical insurance agreement and the liquidated damages paid by them shall not be treated as medical insurance arrears.

Article 14　Designated retail pharmacies should strictly implement the medical insurance payment policy. Encourage the purchase of drugs on the platform specified by the administrative department of medical security, and truly record the situation of "purchase, sale and storage".

Article 15　Designated retail pharmacies should set prices in accordance with the principles of fairness, reasonableness, honesty and credit and consistency of quality and price, and abide by the drug price policy formulated by the administrative department of medical security.

Article 16　Designated retail pharmacies should sell prescription drugs in the medical insurance catalogue by prescription, and pharmacists should review and sign the prescription and then adjust and distribute the drugs. External prescriptions must be issued by doctors in designated medical institutions and signed by doctors. Designated retail pharmacies can sell drugs with electronic prescriptions issued by designated medical institutions.

Article 17　Designated retail pharmacies shall organize medical insurance management personnel to participate in publicity and training organized by the administrative department of medical security or agencies.

Designated retail pharmacies shall organize the training of relevant systems and policies of medical insurance funds, regularly check the use of medical insurance funds of their own units, and promptly correct the irregular use of medical insurance funds.

Article 18　Designated retail pharmacies hang the logo of designated retail pharmacies in a unified format in a prominent position.

Article 19　Designated retail pharmacies should upload information on the varieties, specifications, prices and expenses of drugs purchased by the insured to the overall regional agencies in a timely and truthful manner as required, and regularly report to the agencies the "purchase, sale and storage" data of drugs in the medical insurance catalogue, and be responsible for its authenticity.

Article 20　Designated retail pharmacies shall cooperate with agencies to carry out medical insurance cost audit, audit inspection, performance appraisal and other work, accept the supervision and inspection of the administrative department of medical security, and provide relevant materials in accordance with the provisions.

Article 21　Designated retail pharmacies should check the valid identity certificate of the insured when providing drug services, so that the person’s certificate is consistent. Under special circumstances, if you purchase drugs for others, you should show your ID card and that of the person being purchased. To provide the insured with the direct settlement documents and related materials for the medical insurance drug expenses, and the insured or the drug purchaser shall sign the drug purchase list for confirmation. If a drug is purchased with an external prescription, the identity of the prescription user and the insured shall be verified.

Article 22　Designated retail pharmacies should keep prescriptions and drug purchase lists for 2 years in the medical insurance catalogue of the insured for verification by the medical security department.

Article 23　Designated retail pharmacies should do a good job in the security of information systems related to medical insurance, abide by the relevant systems of data security, and protect the privacy of insured persons. When the designated retail pharmacies reinstall the information system, they shall keep the technical interface standard of the information system effectively connected with the medical insurance information system, and timely, comprehensively and accurately transmit the relevant data required for medical insurance settlement and audit to the medical insurance information system according to the regulations.

Chapter IV Handling Management Services

Article 24　Agencies have the right to grasp the operation and management of designated retail pharmacies, and obtain information and data needed for medical insurance cost audit, performance appraisal and financial bookkeeping from designated retail pharmacies.

Article 25　The agency shall improve the process management of fixed-point application, organization evaluation, agreement signing, agreement performance, agreement modification and dissolution, formulate handling procedures, and provide high-quality and efficient handling services for fixed-point retail pharmacies and insured persons.

Article 26　Agencies should do a good job in the publicity and training of medical security policies, management systems, payment policies and operational procedures of designated retail pharmacies, and provide medical security consultation and inquiry services.

Article 27　The agency shall implement the medical insurance payment policy and strengthen the management of the medical insurance fund.

Article 28　The agency shall establish a sound internal control system, and clarify the post responsibilities and risk prevention and control mechanisms for the audit, settlement, disbursement and audit of medical insurance expenses of designated retail pharmacies. Improve the collective decision-making system for major medical insurance drug expenses.

Article 29　The agency shall strengthen the management of medical insurance fund expenditure, and timely audit the medical insurance drug expenses through intelligent audit, real-time monitoring and on-site inspection. Conduct regular and irregular inspections and audits of designated retail pharmacies, and timely and fully allocate medical insurance expenses to designated retail pharmacies according to the medical insurance agreement. In principle, the medical insurance expenses that meet the requirements shall be allocated within 30 working days after the designated retail pharmacies declare.

Article 30　The designated retail pharmacies shall not pay the illegal medical insurance expenses after examination and verification.

Article 31　The agency shall pay the drug expenses incurred by the insured in the designated retail pharmacies in accordance with the law.

Insured persons should purchase drugs at designated retail pharmacies with their valid identity certificates. Do not rent (borrow) my valid identity certificate to others, and do not take medical insurance funds. The medical insurance fund will not pay the drug expenses incurred in non-designated retail pharmacies.

Article 32　The agency shall disclose the data set and interface standard of the medical insurance information system to the public. Designated retail pharmacies independently choose the operation and maintenance suppliers of relevant information systems connected with medical insurance. The agency shall not charge any fees and designate suppliers in any name.

Article 33　The agency shall abide by the relevant data security system, protect the privacy of the insured, and ensure the safety of the medical insurance fund.

Article 34　The handling agency or the third party agency entrusted by it shall conduct performance appraisal on the designated retail pharmacies and establish a dynamic management mechanism. The assessment results are linked to year-end liquidation, quality deposit refund and renewal of medical insurance agreement. The performance appraisal method shall be formulated by the national medical security department, and the provincial medical security department may formulate specific assessment rules, and the agency shall be responsible for organizing the implementation.

Article 35　Agencies found that the designated retail pharmacies in violation of the medical insurance agreement, according to the medical insurance agreement to take the following treatment:

(1) Interviewing the legal representative, principal responsible person or actual controller;

(two) to suspend the settlement, not to pay or recover the paid medical insurance expenses;

(three) require the designated retail pharmacies to pay liquidated damages in accordance with the medical insurance agreement;

(four) to suspend or terminate the medical insurance agreement.

Article 36　If the agency violates the medical insurance agreement, the designated retail pharmacy has the right to request correction or submit it to the administrative department of medical security for coordination and rectification, and may also apply for administrative reconsideration or bring an administrative lawsuit according to law.

If the administrative department of medical security finds that the agency violates the medical insurance agreement, it can take the following measures according to the circumstances: interviewing the main person in charge, making rectification within a time limit, and informed criticism, and punishing the relevant responsible personnel according to the law and regulations.

If the administrative department of medical security finds that the agency violates the relevant laws, regulations and rules, it shall handle it according to the law.

Chapter V Dynamic Management of Designated Retail Drugstores

Article 37　Where important information such as the name, legal representative, person in charge of the enterprise, actual controller, registered address and drug business scope of the designated retail pharmacy changes, an application for change shall be submitted to the overall regional agency within 30 working days from the date of approval by the relevant department, and other general information changes shall be promptly informed in writing.

Article 38　The renewal should be made by the designated retail pharmacies to apply to the agency 3 months before the expiration of the medical insurance agreement or organized by the agency. Co-ordinate regional agencies and designated retail pharmacies to negotiate the renewal of the medical insurance agreement, and the two sides will decide whether to renew it according to the performance and performance appraisal of the medical insurance agreement. If consensus is reached, the medical insurance agreement can be renewed; If no agreement is reached, the medical insurance agreement will be terminated.

Article 39　The suspension of medical insurance agreement means that the agency and the designated retail pharmacy suspend the performance of the medical insurance agreement, and the medical insurance expenses incurred during the suspension period will not be settled. At the end of the suspension period, if the validity period of the medical insurance agreement is not exceeded, the medical insurance agreement can continue to be performed; If the medical insurance agreement expires, the medical insurance agreement will be terminated.

Designated retail pharmacies can apply for suspending the medical insurance agreement, and with the consent of the agency, they can suspend the medical insurance agreement, but the suspension time shall not exceed 180 days in principle. If the designated retail pharmacies fail to apply for continuing to perform the medical insurance agreement after the medical insurance agreement is suspended for more than 180 days, the medical insurance agreement will be automatically terminated in principle. Designated retail pharmacies in any of the following circumstances, the agency shall suspend the medical insurance agreement:

(a) according to the daily inspection and performance appraisal, it is found that it may cause significant risks to the safety of the medical insurance fund and the rights and interests of the insured;

(two) failing to provide the relevant data to the administrative department of medical security and the agency in accordance with the provisions, or the data provided is untrue;

(three) according to the medical insurance agreement, the medical insurance agreement should be suspended;

(four) other circumstances that should be suspended as stipulated by laws, regulations and rules.

Article 40　The termination of the medical insurance agreement refers to the termination of the medical insurance agreement between the agency and the designated retail pharmacies, the agreement relationship no longer exists, and the medical expenses generated after the termination of the medical insurance agreement are no longer settled. Designated retail pharmacies in any of the following circumstances, the agency shall terminate the medical insurance agreement, and announce to the public the list of retail pharmacies that terminate the medical insurance agreement:

(a) the medical insurance agreement has been suspended for two or more times during the validity period, or the medical insurance agreement has not been rectified as required or the rectification is not in place;

(two) the occurrence of major drug quality and safety incidents;

(three) to resort to deceit and other improper means to apply for a fixed point;

(4) defrauding the medical insurance fund by forging or altering the bills and accounts of the "purchase, sale and storage" of medical insurance drugs, forging prescriptions or the list of expenses of insured persons;

(5) Swapping non-medical insurance drugs or other commodities into medical insurance drugs, reselling medical insurance drugs or taking medical insurance funds;

(six) settlement of medical insurance expenses for non-designated retail pharmacies, designated retail pharmacies or other institutions during the suspension of medical insurance agreements;

(seven) the medical insurance settlement equipment lent or donated to others, change the use of the site;

(eight) refusing, obstructing or not cooperating with the agency to carry out intelligent audit and performance appraisal, etc., and the circumstances are bad;

(nine) it is found that major information has changed but has not been changed;

(ten) the administrative department of medical security or the relevant law enforcement agencies in the administrative law enforcement, found that there are major violations of laws and regulations in designated retail pharmacies and may cause major losses to the medical security fund;

(eleven) the drug business license or business license has been revoked or cancelled;

(twelve) failing to perform the administrative punishment decision made by the administrative department of medical security according to law;

(thirteen) the legal representative, the person in charge of the enterprise or the actual controller can not fulfill the medical insurance agreement, or there is illegal and untrustworthy behavior;

(14) If the legal representative, the person in charge of the enterprise or the actual controller of the headquarters of the designated retail drugstore chain operation violates laws and regulations, one of the branch retail pharmacies of the chain retail drugstore is terminated, and the other branch retail pharmacies with the same legal representative, the person in charge of the enterprise or the actual controller also terminate the medical insurance agreement;

(fifteen) the designated retail pharmacies offered to terminate the medical insurance agreement and agreed by the agency;

(sixteen) according to the medical insurance agreement, the agreement should be terminated;

(seventeen) other circumstances that should be lifted as stipulated by laws, regulations and rules.

Article 41　Designated retail pharmacies voluntarily propose to suspend the medical insurance agreement, terminate the medical insurance agreement or not renew it, and should apply to the agency 3 months in advance. The medical insurance agreement between the agency in the overall planning area at the prefecture level and above and the designated retail pharmacy is suspended or terminated, and the medical insurance agreement of the retail pharmacy in other overall planning areas is also suspended or terminated.

Article 42　Designated retail pharmacies and regional agencies as a whole have disputes over the signing, performance, modification and dissolution of medical insurance agreements, which can be resolved through self-negotiation or requested by the administrative department of medical security at the same level for coordination, and can also bring an administrative reconsideration or administrative lawsuit.

Chapter VI Supervision of Designated Retail Drugstores

Article 43　The administrative department of medical security shall supervise the fixed-point application, application acceptance, professional evaluation, agreement conclusion, agreement performance and cancellation, and guide and supervise the construction of internal control system, audit and disbursement of medical insurance expenses of agencies.

The administrative department of medical security shall supervise the implementation of medical insurance agreements, the use of medical insurance funds and drug services of designated retail pharmacies through on-site inspections, spot checks, intelligent monitoring and big data analysis.

Article 44　Medical security administrative departments and agencies should broaden the channels of supervision, innovate the ways of supervision, conduct social supervision on designated retail pharmacies through satisfaction surveys, third-party evaluations, and hiring social supervisors, unblock the channels of reporting complaints, and find problems in time and deal with them.

Article 45　If the administrative department of medical security finds that there is a breach of contract in designated retail pharmacies, it shall promptly order the agency to deal with it in accordance with the medical insurance agreement. Designated retail pharmacies that violate laws and regulations shall be dealt with according to laws and regulations.

Article 46　When an agency finds a breach of contract, it shall promptly deal with it in accordance with the medical insurance agreement.

When the agency suspends or cancels the medical insurance agreement, it shall promptly report to the administrative department of medical security at the same level.

If the administrative department of medical security finds that there is a breach of contract in designated retail pharmacies, it shall promptly order the agency to deal with it according to the medical insurance agreement, and the agency shall deal with it in a timely manner according to the agreement.

When the administrative department of medical security investigates and deals with violations of laws and regulations according to law, it thinks that the facts about the illegal clues handed over by the agency are unclear, and may organize supplementary investigations or request the agency to supplement materials.

Chapter VII Supplementary Provisions

Article 47　The fixed-point management of medical insurance such as basic medical insurance for employees, basic medical insurance for urban and rural residents, maternity insurance, medical assistance and serious illness insurance for residents shall be implemented in accordance with these measures.

Article 48　The agency in these Measures is a functional institution with legal authorization to implement medical security management services, and it is the main body of medical security management.

Retail pharmacies are pharmaceutical retail enterprises that comply with the provisions of the Drug Administration Law of People’s Republic of China (PRC) and obtain pharmaceutical business licenses.

Designated retail pharmacies refer to physical retail pharmacies that voluntarily sign medical insurance agreements with regional agencies as a whole to provide pharmaceutical services for the insured.

The medical insurance agreement refers to the agreement signed by the agency and the retail pharmacy through negotiation, which is used to regulate the rights, obligations and responsibilities of both parties.

Article 49　The administrative department of medical security in the State Council makes and regularly revises the model of medical insurance agreement, and the national medical insurance agency formulates handling procedures and guides all localities to strengthen and improve the management of the agreement. On this basis, the medical security administrative departments and agencies at the prefecture level and above can formulate the model agreement and handling procedures in the local area according to the actual situation. The contents of the agreement should be consistent with the changes of laws, regulations, rules and medical insurance policies. When the medical insurance administrative department adjusts the contents of the medical insurance agreement, it should seek the opinions of the relevant designated retail pharmacies.

Article 50　These Measures shall be interpreted by the administrative department of medical security of the State Council, and shall come into force as of February 1, 2021.

Cctv news(News Network): In the past few days, medical institutions at all levels in various places have gone all out to do a good job in the advancement of diagnosis and treatment and the treatment of patients.

At present, the epidemic situation in Beijing has generally slowed down. In order to alleviate the pressure of treatment in secondary and tertiary hospitals, various community health service centers in Beijing have tried their best to improve their service capacity and provide oxygen filling services to residents in need. A total of 287 inpatient beds were added in 21 community health centers under the jurisdiction of Fengtai District, providing residents with in-patient treatment and other services nearby.

Shanghai co-ordinates medical resources and implements classified diagnosis and treatment. The city’s 249 community health service centers have formed a one-to-one cooperative relationship with 53 district-level hospitals and 17 municipal general hospitals.

Sichuan has implemented the responsibility system of lump-sum responsibility and established a three-level severe treatment system, covering 66 third-level hospitals and 287 district-level hospitals in 21 cities and prefectures in the province. At present, the utilization rates of total beds and severe beds in medical institutions above the second level are 88.91% and 64.87% respectively.